Insider Transactions in Q2 2025 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2025
|
Guy P Sansone Director |
BUY
Open market or private purchase
|
Direct |
1,570
+11.56%
|
$98,910
$63.7 P/Share
|
|
May 31
2025
|
Brian Newman EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,861
+50.0%
|
$1,399,104
$64.04 P/Share
|
|
May 31
2025
|
Amy Compton Phillips EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,091
+30.26%
|
$3,397,824
$64.04 P/Share
|
|
May 15
2025
|
Guy P Sansone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+16.6%
|
$124,620
$60.47 P/Share
|
|
May 15
2025
|
Douglas H. Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+32.69%
|
$124,620
$60.47 P/Share
|
|
May 15
2025
|
J Scott Kirby Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,769
+19.63%
|
$166,140
$60.47 P/Share
|
|
May 15
2025
|
Michael F Mahoney Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+2.22%
|
$8,640
$60.47 P/Share
|
|
May 15
2025
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+32.69%
|
$124,620
$60.47 P/Share
|
|
May 15
2025
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,232
+15.81%
|
$133,920
$60.47 P/Share
|
|
May 15
2025
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,232
+1.74%
|
$133,920
$60.47 P/Share
|
|
May 15
2025
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
692
+50.0%
|
$41,520
$60.47 P/Share
|
|
May 15
2025
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,263
+5.46%
|
$135,780
$60.47 P/Share
|
|
May 06
2025
|
Larry Robbins Director |
SELL
Open market or private sale
|
Indirect |
150,000
-1.8%
|
$9,900,000
$66.67 P/Share
|
|
May 05
2025
|
Larry Robbins Director |
SELL
Open market or private sale
|
Indirect |
1,323,932
-6.92%
|
$88,703,444
$67.68 P/Share
|
|
May 02
2025
|
Larry Robbins Director |
SELL
Open market or private sale
|
Indirect |
2,276,068
-6.65%
|
$154,772,624
$68.48 P/Share
|
|
Apr 01
2025
|
Prem S Shah EVP and Group President |
BUY
Grant, award, or other acquisition
|
Direct |
26,478
+31.28%
|
$1,774,026
$67.98 P/Share
|
|
Apr 01
2025
|
Prem S Shah EVP and Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-2.69%
|
$87,636
$67.98 P/Share
|
|
Apr 01
2025
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,847
-3.43%
|
$123,749
$67.98 P/Share
|
|
Apr 01
2025
|
Samrat S. Khichi EVP, CPO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
16,181
+28.02%
|
$1,084,127
$67.98 P/Share
|
|
Apr 01
2025
|
Samrat S. Khichi EVP, CPO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-6.66%
|
$103,716
$67.98 P/Share
|
|
Apr 01
2025
|
Tilak Mandadi EVP, Chief Experience & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
20,594
+15.05%
|
$1,379,798
$67.98 P/Share
|
|
Apr 01
2025
|
Tilak Mandadi EVP, Chief Experience & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
995
-2.24%
|
$66,665
$67.98 P/Share
|
|
Apr 01
2025
|
Steven H Nelson EVP and President, Aetna |
BUY
Grant, award, or other acquisition
|
Direct |
21,329
+50.0%
|
$1,429,043
$67.98 P/Share
|
|
Apr 01
2025
|
Heidi B Capozzi EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,768
+10.99%
|
$788,456
$67.98 P/Share
|
|
Apr 01
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,710
+37.32%
|
$985,570
$67.98 P/Share
|
|
Apr 01
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,266
-16.78%
|
$151,822
$67.98 P/Share
|
|
Apr 01
2025
|
Thomas F. Cowhey EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
16,181
+28.24%
|
$1,084,127
$67.98 P/Share
|
|
Apr 01
2025
|
Thomas F. Cowhey EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,203
-6.0%
|
$214,601
$67.98 P/Share
|